Connect with us

Cannabis

Backstopped by Science, CBD Unlimited Aiming for 30,000 Distribution Points

Published

on

2018 was a year of milestones for the cannabis markets, including Canada becoming the first Group of Seven country to legalize recreational use and the number of U.S. states where medical or recreational marijuana is legal rising to 33 and 10, respectively, along with the District of Columbia.  A watershed moment happened in the industrial hemp space too, with the passage of the U.S. Farm Bill 2018 removing the plant from the federal controlled substance list, effectively making it a legal agricultural commodity as of the start of 2019.

Hemp is a variety of the cannabis sativa plant that does not contain any meaningful levels of THC (tetrahydrocannabinol), the marijuana component responsible for the psychotropic high.  What it does contain is CBD (cannabidiol), a non-intoxicating compound of cannabis that is widely trumpeted for a litany of therapeutic benefits, including reducing pain, nausea, anxiety and inflammation.

The legalization of industrial hemp will certainly make CBD one of the most active areas within the broader cannabis markets in 2019.

As noted by CBD Unlimited (OTC: EDXC) Chairman and CEO Todd Davis in a recent interview with SNNLive, sourcing is something that consumers need to be aware of because there will be a battery of companies jumping on the bandwagon to sell something that is hot.  Eventually, the Farm Bill will help correct any supply/demand imbalance, at which time quality of product will again move to the foreground.

CBD Unlimited has been a pioneer in the CBD space, building its portfolio of products on science, science that shows CBD attaches to the CB2 receptor.  The CB2 receptor is distributed throughout the entire body of humans and animals.  By attaching to the CB2 receptor, CBD activates a channel that alleviates or stops pain without unpleasant side effects.

The company offers an array of CBD products for both people and their pets.  The product lineup includes oils, concentrates, topicals, beverages and – for dogs and cats – Phyto-Bites CBD soft chews.  Because the company specifically extracts and isolates only the CBD molecule from industrial hemp, their products are legal in all 50 states.

While there is a broad spectrum of applications, the company’s target market is adults over age 50 in a state of chronic inflammation and pain that are looking for a natural solution without the risks associated with pharmaceutical drugs.

Davis keeps CBD in perspective, viewing it not a miracle cure that is a replacement for everything, but as a support mechanism that is changing the quality of life for many people.  His company has kept the business model simple (in a manner of speaking), taking a molecule that is known to have remarkable therapeutic benefits and turning it into something that everyday people can use and doctors can adopt into their practices.

Against the backdrop of a favorable consumer environment, the growth driver for CBD Unlimited is distribution.   A pilot program pushed the company over its first target of 1,000 distribution points in 2018.  To help with the initiative to reach 5,000 distribution points in 2019, Davis recruited Dustin Sullivan as Chief Operating Officer.  Sullivan brings his experience from 18 years at Walgreens where he trained and work with people throughout the big box pharmacy business.  Sullivan’s expertise has resulted in the company getting in front of the biggest buyers in the U.S. as part of the 2019 target and next milestone of at least 30,000 distribution points in the next one-two years.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material. style���

Cannabis

Medicine Man Technologies: Showing Cannabis Companies How It’s Done

Published

on

2018 brought us legal recreational marijuana throughout Canada, legalization of medical cannabis in New Zealand, de-scheduling of industrial hemp in the U.S. via the Farm Bill, more U.S. states legalizing medical (now 33 in total plus D.C.) and recreational (10 states plus D.C.) cannabis and much more that further legitimized the industry.  According to the latest Gallup Poll, two in three Americans now supports legalizing marijuana, the highest level ever for advocacy.

It seems that the tailwinds for the industry continue to blow mightily.  With this rapid growth, companies worldwide are looking to get a piece of the burgeoning market.  As many have found out in recent years, though, it isn’t as simple as just putting some seeds in a row of planters.  It’s big business that will get much, much bigger and it takes a great deal of knowledge and experience to avoid what could be disastrous pitfalls to upstarts.

From its headquarters in Denver, Colorado, Medicine Man Technologies (OTCQX: MDCL) is there to provide consult for companies across a full menu of topics.  A la cart or comprehensive services are offered depending on exactly what the client needs, covering everything from obtaining a license to standard operating procedure for handling a retail customer and everywhere in between.  For some, the company has come in and effectively turned-around a stumbling grow operation with its program called “Cultivation MAX.”  With this program, the company looks to replicate its own grow success, showing the client the intricacies necessary to have a repeatable, successful harvests.

To help with that matter, the company offers Success Nutrients®, a nine-product nutrient line with the needed ingredients to simultaneously maximize per-foot flower yield and growth of the highest quality flowers.

The company has deep experience throughout the entire supply chain, including parent company, Medicine Man Denver, being the largest cultivation/retail facility in Colorado.  The parent company has been operating in the cannabis industry for a number of years, amassing the intellectual property, technology and experience to help others achieve success.  To that end, Medicine Man Technologies operates in several capacities, namely licensing its technology and operating as a cannabis consulting outfit, with investors, legal and licensed commercial cultivation and dispensary operators and new companies looking to participate in the cannabis industry.

The company works with, or has worked with, clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Oklahoma, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa.   Last summer, Medicine Man Technologies granted Canada House Wellness Group (CSE: CHV) exclusive licensing rights to its IP and products lines (Three a Light® and Success Nutrients®) for the Canadian marketplace, along with assignment of an existing Cultvation MAX agreement to Canada House in exchange for an initial payment of C$4.65 million in cash and stock and future fees based on revenue in Canada.

The Master License Agreement was a boon to the company’s financial performance in the quarter ended September 30, 2018 and for the year-to-date figures, with total income from January through September totaling $9.92 million and net profit coming in at $5.16 million, or 19 cents per share.  It’s worth noting that while the license agreement certainly was material, organic growth was strong also.  For the nine-month period, organic revenue was $3.78 million, up from $2.49 million in the year prior period.

These developments, along with a new Chief Operating Officer, Joe Puglise – the former President of New York properties for iHeartMedia – and what looks to be a general revitalization of so-called pot stocks recently, should have the investment community watching for what the market has to offer in 2019 and the continued evolution of Medicine Man Technologies.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material.

Continue Reading

Breaking

A New Spin on CBD: Quanta Upping the Game with Bioenergy

Published

on

Cannabidiol, or CBD for short, a component of cannabis, is all the rage today, underscored by President Trump last week signing the U.S. Farm Bill 2018 into law. After decades of being held to the same standard as cannabis that contains THC, hemp is finally removed from the Controlled Substance Act, effectively making hemp-based CBD legal at the federal level.

Cannabis and hemp are similar with one major differentiator: THC (tetrahydrocannabinol), the cannabinoid in cannabis responsible for the psychoactive high, or “stoned” feeling from ingesting marijuana. Hemp contains little to no THC, but does contain CBD, a non-psychotropic cannabinoid widely acclaimed for a litany of medical uses, including applications for hard-to-treat diseases like epilepsy and PTSD, as well as more casual uses, such as skincare.

With the passage of the Farm Bill, hemp-based CBD – which still falls under the regulatory scrutiny of the U.S. Food and Drug Administration – is legal for a bevy of development activity.

The scientists at Quanta (OTC: QNTA) are putting a new spin on cannabinoids, specifically CBD, amplifying the benefits by using the combination of quantum physics and biochemistry to increase bioenergy within the cell. As explained in a corporate video, this produces a better chemical reaction in the body.

The science is based in part on principles of quantum physics proving that everything in the universe is energy and has its own vibration, or vibrational frequency more specifically, including cannabinoid receptors. Cannabis, by virtue of its properties as a plant, is losing vibrational power every day. Quanta uses a patented technology to retrain the vibrations within cannabinoids, which raises their bioenergy, until they have identical frequencies to the body’s cannabinoid receptors.

When these matching frequencies combine, the highest possible response is the result and the CBD is absorbed into the body more efficiently with little to no side effect. This takes each element in Quanta’s formula to peaks levels of performance, meaning the user enjoys a better experience in reduction of things like pain, inflammation, stiffness and anxiety that CBD is heralded for delivering.

Quanta’s lead product is CBD Muscle Rub, a combination of 13 natural elements including turmeric, arnica and polarized CBD, administered topically for the relief of muscle and joint pain and stiffness.

While the initial focus is on hemp-based CBD, the technology is available for licensing or product development that can be applied to all types of plant matter to enhance energy in naturally occurring molecules utilizing the same properties of the Law of Vibration and the fact that humans are bio-electric beings. In addition to the effect on muscles and joints, the complete Quanta process, which involves identifying natural elements by their frequency and using magnetic and electric frequencies to illicit changes at the sub-atomic level to make the

targeted molecules move faster to create a bond in receptors for an energized and frictionless experience, have been shown to significantly reduce anxiety, paranoia, cognitive haze and drowsiness.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material.

Continue Reading

Breaking

The Alkaline Water Company Expanding as Cannabis Industry Heats Up

Published

on

It’s been another busy month in the cannabis industry, including several watershed moments. The 2018 Farm Bill, which will legalize industrial hemp, passed in Congress and is awaiting being signed into law by President Trump. Cannabis producer Tilray (NASDAQ: TLRY) partnered with drug giant Novartis (NYSE: NVS) to distribute medical marijuana where legal around the world. Beer juggernaut Anheuser-Busch InBev (NYSE: BUD) also partnered with Tilray, with the two agreeing to collaborate on a joint venture to make new CBD- and THC-infused beverages.

These developments dovetail with the decisions of The Alkaline Water Company (NASDAQ: WTER)(TSX-V: WTER) to expand its portfolio both in product and distribution. The Scottsdale, Arizona-based company is already the best-selling bulk alkaline water in the U.S. with its Alkaline88® sold in nearly 50,000 stores, including leading retailers Kroger (NYSE: K), Albertsons/Safeway, Walmart (NYSE: WMT) and CVS (NYSE: CVS).

In November, the company set a sales record, generating $3.1 million in sales during the month.

Looking to capitalize on the growing trend to shift away from sugary drinks towards functional beverages, including those containing CBD (cannabidiol), The Alkaline Water Company is widening its product offerings to include flavored and hemp-infused beverages. CBD is a component of cannabis and its cousin, hemp. Hemp is clearly differentiated from cannabis in that while it does have CBD, it does not contain (or only has trace amounts of) THC, the psychotropic constituent of cannabis responsible for the “high” commonly associated with marijuana.

CBD is trumpeted to have a multitude of therapeutic benefits, ranging from anti-inflammatory to new therapeutics for hard-to-treat diseases like cancer and epilepsy. With consumers becoming more health conscious all the time, the global functional beverage market is forecast by Grand View Research to reach $93.68 billion in 2019.

The expected passage of the 2018 Farm Bill presents The Alkaline Water Company with a unique opportunity to become the first national U.S. beverage firm to bring true water-soluble, full-spectrum features of bioactive CBD molecules from hemp plants via its A88 Infused Beverage Division. Late in November, the company inked a deal with Infusion Biosciences to utilize Infusion’s proprietary Aqueous Phytorecovery Process technology that uniformly dissolves CBD directly in water. Generally speaking, manufacturers are challenged by the hydrophobic nature of CBD, meaning that they must resort to using chemicals or additives for infusion. The quality and purity of Infusion’s technology fits squarely with Alkaline’s mantra a “clean beverages” that are free of chemicals and additives.

The new infused beverages will be marketed under the brand SOOTHE™ and are expected to be available during the first quarter of 2019 based upon the contention that all necessary approvals are in place.

The new products can be rolled into Alkaline Water Company’s expansive – and growing – distribution network. In its bid to expand internationally, the company this month teamed up with British Columbia, Canada-based World Choice Bottling for production of Alkaline88® early in 2019. Through the agreement, Alkaline88® will be made available for sale in the Canadian markets and throughout the fast-growing Asian markets, particularly China, where WTER management says it has already made substantial progress in the last 14 months.

Online Media Group, Inc. is not registered with any financial or securities regulatory authority and holds no investment licenses and does not provide, nor claims to provide, investment advice. We are a publisher of original and third party news and information. This article is sponsored content and is neither an offer nor recommendation to buy, sell or hold any security. The views expressed are our own and not intended to be the basis for any investment decision. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader’s attention to the fact that Online Media Group, Inc. received $1,333 in compensation from IRTH Communications for content creation, advertising and distribution services related to this material.

Continue Reading

Most Popular